TRAK2 has been reported as a novel regulator of ATP-binding cassette, sub-family A member 1 (ABCA1) expression, cholesterol efflux and HDL biogenesis, and therefore, TRAK2 may be an important target in the treatment of cardiovascular disorders [36]. The gene discussed is ABCA1; the disease is cardiovascular disorder.